Showing results (251-260 of 270) with videos related to
Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|March 26, 2014
Eligibility for renal denervation: experience at 11 European expert centersAlexandre Persu, Yu Jin, Marie Baelen, et al.Diabetes, Obesity & Metabolism|March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D modelMarga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.Nature Methods|June 23, 2014
Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomicsAlicia Lundby, Elizabeth J Rossin, Annette B Steffensen, et al.Cardiovascular Research|April 14, 2020
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patientsMarco Pappaccogli, Silvia Di Monaco, Ewa Warchoł-Celińska, et al.Journal of Thrombosis and Haemostasis : JTH|July 3, 2020
Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosisLisette F van Dam, Gargi Gautam, Charlotte E A Dronkers, et al.Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.Blood|February 5, 2020
Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosisLisette F van Dam, Charlotte E A Dronkers, Gargi Gautam, et al.Blood Advances|March 4, 2021
Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosisLisette F van Dam, Wilbert B van den Hout, Gargi Gautam, et al.European Journal of Preventive Cardiology|May 19, 2021
Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectivenessSteven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.The Journal of Experimental Medicine|October 15, 2024
Uniting education, research, healthcare, and society to advance women's heart healthMichael Y Schakelaar, Annemieke Maas, Anne-Mar L N van Ommen, et al.Pageof 27